Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Vincent Giacalone
mi
from
Emerson, NJ
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Vincent Giacalone
mi
from
Emerson, NJ
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
St. Luke's Roosevelt Hospital Center
mi
from
New York, NJ
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
St. Luke's Roosevelt Hospital Center
mi
from
New York, NJ
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Overglook Hospital Wound Healing Program
mi
from
Summit, NJ
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Overglook Hospital Wound Healing Program
mi
from
Summit, NJ
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Harrisburg Foot and Ankle Center
mi
from
Harrisburg, PA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Harrisburg Foot and Ankle Center
mi
from
Harrisburg, PA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Center for Advanced Wound Care
mi
from
Reading, PA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Center for Advanced Wound Care
mi
from
Reading, PA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Arlington Research Center
mi
from
Arlington, TX
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Arlington Research Center
mi
from
Arlington, TX
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Wound Care Consultants
mi
from
Dallas, TX
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Wound Care Consultants
mi
from
Dallas, TX
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Southwest Regional Wound Care Center
mi
from
Lubbock, TX
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Southwest Regional Wound Care Center
mi
from
Lubbock, TX
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Peripheral Vascular Associates
mi
from
San Antonio, TX
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Peripheral Vascular Associates
mi
from
San Antonio, TX
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
University Of Utah Hospital
mi
from
Salt Lake City, UT
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
University Of Utah Hospital
mi
from
Salt Lake City, UT
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Englewood Hospital and Medical Center
mi
from
Englewood, NJ
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Englewood Hospital and Medical Center
mi
from
Englewood, NJ
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Lake Shore Pediatrics
mi
from
Libertyville, IL
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Lake Shore Pediatrics
mi
from
Libertyville, IL
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Providence Sacred Heart
mi
from
Spokane, WA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Providence Sacred Heart
mi
from
Spokane, WA
Intravascular Near Infrared Spectroscopy (NIRS) Bifurcation - Lipid Core Plaque Shift Study
Study of Lipid Core Plaque Shift at Sites of Native Coronary Artery Bifurcation
Status: Archived
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Intravascular Near Infrared Spectroscopy (NIRS) Bifurcation - Lipid Core Plaque Shift Study
Study of Lipid Core Plaque Shift at Sites of Native Coronary Artery Bifurcation
Status: Archived
Updated: 1/1/1970
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Using Duke Activity Status Index (DASI) to Select Optimal Cardiac Stress Tests
Clinical Role of the Duke Activity Status Index in the Selection of the Optimal Type of Stress Myocardial Perfusion Imaging Study in Patients With Known or Suspected Ischemic Heart Disease
Status: Archived
New York University Langone Medical Center
mi
from
New York, NY
Using Duke Activity Status Index (DASI) to Select Optimal Cardiac Stress Tests
Clinical Role of the Duke Activity Status Index in the Selection of the Optimal Type of Stress Myocardial Perfusion Imaging Study in Patients With Known or Suspected Ischemic Heart Disease
Status: Archived
Updated: 1/1/1970
New York University Langone Medical Center
mi
from
New York, NY
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
Clinical Research Facility
mi
from
Miami, FL
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Miami, FL
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
Aurora Memorial Hospital of Burlington
mi
from
Burlington, WI
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
Updated: 1/1/1970
Aurora Memorial Hospital of Burlington
mi
from
Burlington, WI
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
Maine Center for Cancer Medicine and Blood Disorders - Scarborough
mi
from
Scarborough, ME
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
Updated: 1/1/1970
Maine Center for Cancer Medicine and Blood Disorders - Scarborough
mi
from
Scarborough, ME
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
Clinical Research Facility
mi
from
Brooklyn, NY
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Brooklyn, NY
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
Clinical Research Facility
mi
from
Portland, OR
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Portland, OR
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
New York Methodist Hospital
mi
from
Brooklyn, NY
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
Updated: 1/1/1970
New York Methodist Hospital
mi
from
Brooklyn, NY
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
Clinical Research Facility
mi
from
Rapid City, SD
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Rapid City, SD
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
Clinical Research Facility
mi
from
Chattanooga, TN
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Chattanooga, TN
Enhancing Detection of Small Esophageal Varices by PillCam ESO
A New Technique to Enhance Detection of Small Esophageal Varices by PillCam ESO Capsule Endoscopy
Status: Archived
Froedtert Memorial Luthern Hospital
mi
from
Milwaukee, WI
Enhancing Detection of Small Esophageal Varices by PillCam ESO
A New Technique to Enhance Detection of Small Esophageal Varices by PillCam ESO Capsule Endoscopy
Status: Archived
Updated: 1/1/1970
Froedtert Memorial Luthern Hospital
mi
from
Milwaukee, WI
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
University of Colorado, Boulder
mi
from
Boulder, CO
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Updated: 1/1/1970
University of Colorado, Boulder
mi
from
Boulder, CO
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Cleveland Clinic Florida
mi
from
Weston, FL
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Updated: 1/1/1970
Cleveland Clinic Florida
mi
from
Weston, FL
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Saint Joseph's Research Institute
mi
from
Atlanta, GA
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Updated: 1/1/1970
Saint Joseph's Research Institute
mi
from
Atlanta, GA
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Southeastern Center for Clinical Trials
mi
from
Decatur, GA
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Updated: 1/1/1970
Southeastern Center for Clinical Trials
mi
from
Decatur, GA
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Provena St. Joseph's Medical Center
mi
from
Joliet, IL
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Updated: 1/1/1970
Provena St. Joseph's Medical Center
mi
from
Joliet, IL
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Illinois Lung and Critical Care Institute
mi
from
Peoria, IL
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Updated: 1/1/1970
Illinois Lung and Critical Care Institute
mi
from
Peoria, IL
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
St. John's Pediatrics
mi
from
Leavenworth, KA
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Updated: 1/1/1970
St. John's Pediatrics
mi
from
Leavenworth, KA
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Overlook Hospital
mi
from
Morristown, NJ
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Updated: 1/1/1970
Overlook Hospital
mi
from
Morristown, NJ
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
New York Presbyterian Hospital-Weill Cornell Medical Center
mi
from
New York, NY
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Updated: 1/1/1970
New York Presbyterian Hospital-Weill Cornell Medical Center
mi
from
New York, NY
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Stony Brook University Hospital and Medical Center
mi
from
Stony Brook, NY
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Updated: 1/1/1970
Stony Brook University Hospital and Medical Center
mi
from
Stony Brook, NY
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Forsyth Regional Medical Center
mi
from
Winston-Salem, NC
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Updated: 1/1/1970
Forsyth Regional Medical Center
mi
from
Winston-Salem, NC
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Ohio State University
mi
from
Columbus, OH
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Updated: 1/1/1970
Ohio State University
mi
from
Columbus, OH
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Drexel University College of Medicine
mi
from
Philadelphia, PA
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Updated: 1/1/1970
Drexel University College of Medicine
mi
from
Philadelphia, PA
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Research Concepts, Memorial Hermann Healthcare System
mi
from
Houston, TX
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Updated: 1/1/1970
Research Concepts, Memorial Hermann Healthcare System
mi
from
Houston, TX
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Carilion Roanoke Memorial Hospital
mi
from
Roanoke, VA
Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Status: Archived
Updated: 1/1/1970
Carilion Roanoke Memorial Hospital
mi
from
Roanoke, VA
Supervised Treadmill Exercise And Ranolazine For Intermittent Claudication Of Lower Extremities
Supervised Treadmill Exercise And Ranolazine For Intermittent Claudication Of Lower Extremities. THE STERILE TRIAL.
Status: Archived
Wiiliam Beaumont Hospital
mi
from
Royal oak, MI
Supervised Treadmill Exercise And Ranolazine For Intermittent Claudication Of Lower Extremities
Supervised Treadmill Exercise And Ranolazine For Intermittent Claudication Of Lower Extremities. THE STERILE TRIAL.
Status: Archived
Updated: 1/1/1970
Wiiliam Beaumont Hospital
mi
from
Royal oak, MI
The Relative Prevalence and Severity of Autonomic Nervous System Dysfunction
The Relative Prevalence and Severity of Autonomic Nervous System Dysfunction in Diabetic Patients Undergoing Retinal Surgery
Status: Archived
Callahan Eye Foundation Hospital
mi
from
Birmingham, AL
The Relative Prevalence and Severity of Autonomic Nervous System Dysfunction
The Relative Prevalence and Severity of Autonomic Nervous System Dysfunction in Diabetic Patients Undergoing Retinal Surgery
Status: Archived
Updated: 1/1/1970
Callahan Eye Foundation Hospital
mi
from
Birmingham, AL
Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant
Metabolic Syndrome Following Transplant for Leukemia
Status: Archived
Children's Hospital - Boston
mi
from
Boston, MA
Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant
Metabolic Syndrome Following Transplant for Leukemia
Status: Archived
Updated: 1/1/1970
Children's Hospital - Boston
mi
from
Boston, MA
Vascular Inflammation in Adolescents With Type 1 Diabetes
Prevalence of Oxidative Stress, Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness (cIMT) and Biomarkers of Vascular Inflammation in Adolescents With Type-1 Diabetes Mellitus (T1DM)
Status: Archived
Children's Mercy Hospital
mi
from
Kansas City, MO
Vascular Inflammation in Adolescents With Type 1 Diabetes
Prevalence of Oxidative Stress, Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness (cIMT) and Biomarkers of Vascular Inflammation in Adolescents With Type-1 Diabetes Mellitus (T1DM)
Status: Archived
Updated: 1/1/1970
Children's Mercy Hospital
mi
from
Kansas City, MO
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Cardiology Associates of N. Mississippi
mi
from
Tupelo, MS
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Cardiology Associates of N. Mississippi
mi
from
Tupelo, MS
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Arkansas Heart Hospital
mi
from
Little Rock, AK
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Arkansas Heart Hospital
mi
from
Little Rock, AK
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Banner Good Samaritan Hospital
mi
from
Phoenix, AZ
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Banner Good Samaritan Hospital
mi
from
Phoenix, AZ
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Tucson Medical Center
mi
from
Tucson, AZ
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Tucson Medical Center
mi
from
Tucson, AZ
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
ACT / CVRI & Cedar Sinai Medical Center
mi
from
Beverly Hills, CA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
ACT / CVRI & Cedar Sinai Medical Center
mi
from
Beverly Hills, CA